$IVFH Income Statement | Understand Stock

$IVFH

$0.23 -$0.01 (5.02%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Cost of goods sold
Gross margin
Selling, general and administrative expenses
Separation costs - executive officers
Impairment of intangible assets
Total operating expenses
Operating income (loss)
Impairment of investment
Other income
Gain on forgiveness of debt
Interest expense, net
Other income (expense):
Interest income (expense), net
Gain on sale of assets
Other income
Other leasing income
Gain on contingent liability
Impairment of investment
Loss on extinguishment of debt
Total other income (expense)
Net income before taxes
Income tax expense
Net income from continuing operations
Net income (loss) from discontinued operations
Consolidated net income (loss)
Net income per share from continuing operations - basic (in Dollars per share)
Net income per share from continuing operations - diluted (in Dollars per share)
Net income (loss) per share from discontinued operations - basic (in Dollars per share)
Net income (loss) per share from discontinued operations - diluted (in Dollars per share)
Weighted average shares outstanding - basic (in Shares)
Weighted average shares outstanding - diluted (in Shares)

Comments